<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn></journal-meta><article-meta><article-id pub-id-type="pmid">7904475</article-id><article-id pub-id-type="pmc">1968756</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of glutathione S-transferase Pi in non-invasive ductal carcinoma of breast.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bellamy</surname><given-names>C. O.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Harrison</surname><given-names>D. J.</given-names></name></contrib></contrib-group><aff>Department of Pathology, University Medical School, Edinburgh, UK.</aff><pub-date pub-type="ppub"><month>1</month><year>1994</year></pub-date><volume>69</volume><issue>1</issue><fpage>183</fpage><lpage>185</lpage><abstract><p>Glutathione S-transferase Pi (GST P) has been reported to be a marker of dysplastic lesions. For this reason expression of GST P by intraduct breast carcinoma was evaluated by immunohistochemistry. Thirty-seven of 92 carcinomas (40%) were GST P positive. GST P staining did not correlate with histological variables, c-erbB-2 overexpression or with clinical outcome. The GST P status of recurrences did not correlate with that of the index lesion. There is little evidence that GST P is a useful marker of the potential of intraduct breast carcinoma to become invasive.</p><sec sec-type="scanned-figures"><title>Images</title><fig id="F1"><label>Figure 1</label><graphic xlink:href="brjcancer00191-0186-a" xlink:role="184"/></fig><fig id="F2"><label>Figure 2</label><graphic xlink:href="brjcancer00191-0186-b" xlink:role="184"/></fig><fig id="F3"><label>Figure 3</label><graphic xlink:href="brjcancer00191-0187-a" xlink:role="185"/></fig></sec></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="brjcancer00191-0185.tif" xlink:title="scanned-page" xlink:role="183" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00191-0186.tif" xlink:title="scanned-page" xlink:role="184" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00191-0187.tif" xlink:title="scanned-page" xlink:role="185" mimetype="image" mime-subtype="tiff"/></supplementary-material></body></article>

